Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes
NCT03362112 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1713
Last updated 2022-04-14
Summary
Lipoprotein-associated phospholipase A2 (LP-PLA2) is a good marker of cardiovascular risk and inflammation. This study aims at the characteristic and clinical significance of LP-PLA2 test in patients with type 2 diabetes(T2D).
Conditions
- Type2 Diabetes
Sponsors & Collaborators
-
Nanjing First Hospital, Nanjing Medical University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-30
- Primary Completion
- 2016-08-31
- Completion
- 2017-06-01
More Related Trials
-
Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT04971252 ·Status: COMPLETED
-
The Early Predictors for Developing Type 2 Diabetes Mellitus in Patients With Chronic Obstructive Pulmonary Disease
NCT03152994 ·Status: COMPLETED
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
Vascular Function, Fish Protein Hydrolysates and Type 2 Diabetes Mellitus
NCT03318913 ·Status: COMPLETED ·Phase: NA
-
Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding
NCT02849691 ·Status: COMPLETED
-
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
NCT00021944 ·Status: COMPLETED
-
Clinical and MRI Cardiac Biomarkers on Peripheral Arterial Disease in Patients With Long Term DM
NCT02850432 ·Status: UNKNOWN ·Phase: NA
-
Plasma Adiponectin Concentration, Activity and Isoforms in Newly Diagnosed and Untreated Type 2 Diabetes Mellitus
NCT01372852 ·Status: UNKNOWN
-
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
NCT03206593 ·Status: UNKNOWN
-
Cohort Study in Type 2 Diabetes in China
NCT01076023 ·Status: UNKNOWN
-
Platelet Activity in T2DM Using Flowcytometry
NCT04027907 ·Status: UNKNOWN
-
Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements
NCT03060694 ·Status: COMPLETED
-
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129 ·Status: RECRUITING
-
Risk Factors of Incidence of Type 2 Diabetes and Cardiovascular Diseases---Shanghai Baoshan Study
NCT00949416 ·Status: UNKNOWN
-
Research on the Correlation Among Magnetocardiography Patterns and Known Cardiovascular Risk Factors in Diabetic Patients
NCT00989924 ·Status: UNKNOWN
-
Free Fatty Acids and Vascular Function in Subjects With Diabetes
NCT00153179 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients
NCT00155922 ·Status: UNKNOWN
-
Investigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 Diabetes
NCT04851223 ·Status: UNKNOWN
-
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
NCT03084965 ·Status: COMPLETED
-
Nationwide Assessment of Cardiovascular Risk Factors: in Chinese Patients With Type 2 Diabetes
NCT01128205 ·Status: COMPLETED
-
Relation Between Carotid Atheroscerosis With DM &Fatty Liver
NCT05532553 ·Status: UNKNOWN
-
Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients
NCT07005986 ·Status: RECRUITING ·Phase: NA
-
the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)
NCT04835974 ·Status: UNKNOWN ·Phase: NA
-
Association Between Glycaemic Control and Morbi/Mortality After 5 Years of Follow-up in Type 2 Diabetic Patients
NCT01282060 ·Status: UNKNOWN